logo

For the Inventor, By the Inventor

Milan, Italy

Dompé Farmaceutici S.p.a.


USPTO Granted Patents = 49



Trademarks = 15

Forward Citations = 223

Loading Chart...
Loading Chart...

74 inventors (with patents filed for the assignee):

goldMedal Marcello Allegretti (13 out of 38 patents)

silverMedal Andrea Aramini (13 out of 22 patents)

bronzeMedal Gianluca Bianchini (12 out of 14 patents)

4.  Laura Brandolini (9 out of 11 patents)

5.  Giancarlo Tonon (7 out of 8 patents)

6.  Andrea Beccari (6 out of 9 patents)

7.  Samuele Lillini (5 out of 5 patents)

8.  Roberto P Giani (5 out of 8 patents)

9.  Gaetano Clavenna (5 out of 11 patents)

10.  Salvatore Malandrino (4 out of 8 patents)

11.  Giani P Roberto (4 out of 4 patents)

12.  Parini Ettore (4 out of 4 patents)

13.  Carmelo A Gandolfi (4 out of 33 patents)

14.  Marco Mantovanini (4 out of 9 patents)

15.  Ettore Parini (4 out of 5 patents)


49 patents:

1. 12491133 - Deformable container, kit and packaging (2025-12-09),
2. 12365644 - Co-crystal of ketoprofen, lysine and gabapentin, pharmaceutical compositions and their medical use (2025-07-22),
3. 12358950 - IL-17A binding peptides and medical uses thereof (2025-07-15),
4. 12285396 - Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereof (2025-04-29),
5. 12268671 - IL-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathy (2025-04-08),
6. 12186359 - Composition containing branched-chain amino acids (2025-01-07),
7. 12150933 - IL-8 inihibitors for use in the treatment of some urological disorders (2024-11-26),
8. 12133843 - IL-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections (2024-11-05),
9. 12102607 - C5aR inhibitors for use in the treatment of chemotherapy-induced iatrogenic pain (2024-10-01),
10. 12097172 - Prevention and treatment of diabetic nephropathy (2024-09-24),
11. 11969501 - Auris formulations for treating otic diseases and conditions (2024-04-30),
12. 11918653 - Triglyceride otic formulations and uses thereof (2024-03-05),
13. 11660291 - IL-8 inhibitors for use in the treatment of some sarcomas (2023-05-30),
14. 11324630 - Controlled volume dropper (2022-05-10),
15. 11291641 - Prevention and treatment of diabetic nephropathy (2022-04-05),
Dompe' Farmaceutici S.p.a. is an Italian pharmaceutical company founded in 1940. They specialize in the research and development of innovative therapies for various medical fields, including neuroscience, ophthalmology, and rare diseases. Dompe' Farmaceutici is committed to improving patients' lives by providing effective and safe pharmaceutical products. With a strong focus on scientific research, they continuously invest in groundbreaking solutions to address unmet medical needs. For more information about Dompe' and their products, please visit their official website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
49 Patents

#35 in 20122 Milan

#165 in Italy

#13,866 in the World

...
Milan, Italy

Dompé Farmaceutici S.p.a.

Forward Citations = 223

74 inventors:

goldMedal Marcello Allegretti (13 out of 38 patents)

silverMedal Andrea Aramini (13 out of 22 patents)

bronzeMedal Gianluca Bianchini (12 out of 14 patents)

4.  Laura Brandolini (9 out of 11 patents)

5.  Giancarlo Tonon (7 out of 8 patents)

Please report any incorrect information to support@idiyas.com
Loading…